Amicus Therapeutics
FOLD
$10.45
Share price
1.65%
Change (1 day)
-9.45%
Change (1 year)
Categories
Amicus Therapeutics (FOLD) - Total assets
Total assets on the balance sheet as of December 2023 : $0.77 B
According to Amicus Therapeutics 's latest financial reports the company's total assets are $0.77 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Amicus Therapeutics - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.77 B | 7.42% |
| 2022-12-31 | $0.72 B | -19.99% |
| 2021-12-31 | $0.90 B | 2.1% |
| 2020-12-31 | $0.88 B | 4.27% |
| 2019-12-31 | $0.85 B | 7.63% |
| 2018-12-31 | $0.78 B | 25.98% |
| 2017-12-31 | $0.62 B | -39.53% |
| 2016-12-31 | $1.03 B | 14.14% |
| 2015-12-31 | $0.90 B | 332.63% |
| 2014-12-31 | $0.20 B | 64.6% |
| 2013-12-31 | $0.12 B | 15.87% |
| 2012-12-31 | $0.11 B | 57.73% |
| 2011-12-31 | $69.79 M | -37.99% |
| 2010-12-31 | $0.11 B | 31.84% |
| 2009-12-31 | $85.37 M | -33.71% |
| 2008-12-31 | $0.12 B | -22.94% |
| 2007-12-31 | $0.16 B | 180.15% |
| 2006-12-31 | $59.64 M | 108.04% |
| 2005-12-31 | $28.66 M | |
| 2003-12-31 | $0.5 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $46.57 B | 5,887.58% | 🇩🇰 Denmark |
 Biogen BIIB | $26.56 B | 3,315.39% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 9,556.17% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | $0.22 B | -70.51% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.20 B | -73.54% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 779.52% | 🇺🇸 USA |